Abstract
Various compounds, some of which influence immediate allergic reactions in different ways, were examined for inhibitory effects on partially purified human lung tissue cyclic nucleotide phosphodiesterases. Some of the compounds reported to possess antiallergic properties were found to be more potent as inhibitors of a low-Km, cyclic 3',5'-GMP-specific phosphodiesterase than of a corresponding low-Km, cyclic 3',5'-AMP-specific enzyme. For 2-o-propoxyphenyl-8-azapurin-6-one (M & B 22,948), 6-n-butyl-2,8-dicarboxy-4,10-dioxo-1,4,7,10-tetrahydro-1,7-phenanthroline (ICI 74,917), and disodium cromoglycate this selectivity was remarkable; to produce 50% inhibition of enzyme activity, a 10-100-fold lower concentration of these agents was required with the former enzyme than with the latter. Compound 48/80, on the other hand, showed high selectivity as an inhibitor of the cyclic AMP-specific, low-Km phosphodiesterase. Among the reference phosphodiesterase inhibitors examined, theophylline, 3-isobutyl-1-methylxanthine, and papaverine inhibited both low-Km enzymes to a comparable degree, whereas 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (Ro 20-1724) was pronouncedly more active toward the cyclic AMP-specific enzyme. Most compounds examined also inhibited the activity of a high-Km phosphodiesterase which hydrolyzes cyclic AMP and cyclic GMP at comparable rates. Pronounced inhibitory potency was recorded for Dicumarol, doxantrazole, compound 48/80, and papaverine, whereas M & B 22,948 was only slightly effective with this enzyme.
ACKNOWLEDGMENTS We thank our colleagues at Draco for valuable discussions, and Drs. H. Schüller and H. Henriksson, who kindly provided human lung tissue specimens.
- Copyright © 1977 by Academic Press, Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|